grey market glp 1 GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo Glucagon-like Peptide 1 (GLP-1) Market
Description
Consistent adherence to the prescribed dosing schedule is also necessary for achieving the full benefits of the medication, with Semaglutide GLP-1 intended for long-term use in managing obesity as a chronic condition
Incretin mimetics have established a massive market in diabetes and obesity, and have yet to reach their peak potential in these therapeutic areas
They use the same active pharmaceutical ingredient as the branded product - semaglutide or tirzepatide - but they are fundamentally different in regulatory status
While some healthcare providers might consider combining Contrave and Wegovy, there is limited data supporting this approach
doi: 10.1001/jama.2020.14590 [DOI] [PMC free article] [PubMed] [Google Scholar] 4.Sorensen MD Chi T Shara NM, et al
